|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.15 HKD | -3.18% |
|
-10.12% | -20.47% |
| 02-13 | Meituan Provides Earning Guidance for the Year Ended December 31, 2025 | CI |
| 02-13 | Meituan expects loss of RMB23.3 billion to RMB24.3 billion for FY2025 | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -1.4 | -6.9 | -1.76 | 2.09 | 6.71 | |||||
Return on Total Capital | -1.9 | -9.17 | -2.3 | 2.82 | 9.28 | |||||
Return On Equity % | 4.96 | -21.09 | -5.26 | 9.87 | 22.07 | |||||
Return on Common Equity | 4.96 | -21.08 | -5.26 | 9.87 | 22.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.12 | 23.71 | 28.08 | 35.12 | 38.44 | |||||
SG&A Margin | 23.19 | 27.52 | 22.51 | 24.57 | 22.13 | |||||
EBITDA Margin % | 0.36 | -8.88 | 0.06 | 5.08 | 11.4 | |||||
EBITA Margin % | -2.52 | -12.23 | -2.89 | 3.34 | 9.87 | |||||
EBIT Margin % | -2.93 | -12.54 | -3.1 | 3.25 | 9.82 | |||||
Income From Continuing Operations Margin % | 4.13 | -13.14 | -3.04 | 5.01 | 10.61 | |||||
Net Income Margin % | 4.13 | -13.14 | -3.04 | 5.01 | 10.61 | |||||
Net Avail. For Common Margin % | 4.13 | -13.14 | -3.04 | 5.01 | 10.61 | |||||
Normalized Net Income Margin | -1.17 | -7.96 | -2.1 | 2.19 | 6.31 | |||||
Levered Free Cash Flow Margin | -5.62 | -1.01 | 4.02 | 10.75 | 9.19 | |||||
Unlevered Free Cash Flow Margin | -5.43 | -0.64 | 4.47 | 11.08 | 9.44 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.76 | 0.88 | 0.91 | 1.03 | 1.09 | |||||
Fixed Assets Turnover | 11.81 | 9.75 | 9.77 | 11.49 | 12.01 | |||||
Receivables Turnover (Average Receivables) | 44.7 | 56.97 | 63.97 | 64.62 | 65.8 | |||||
Inventory Turnover (Average Inventory) | 217.72 | 123.12 | 107.12 | 94.68 | 85.24 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.73 | 2.16 | 1.87 | 1.82 | 1.94 | |||||
Quick Ratio | 1.26 | 1.78 | 1.53 | 1.49 | 1.62 | |||||
Operating Cash Flow to Current Liabilities | 0.17 | -0.06 | 0.15 | 0.4 | 0.53 | |||||
Days Sales Outstanding (Average Receivables) | 8.19 | 6.41 | 5.71 | 5.65 | 5.56 | |||||
Days Outstanding Inventory (Average Inventory) | 1.68 | 2.96 | 3.41 | 3.85 | 4.29 | |||||
Average Days Payable Outstanding | 44.05 | 37.12 | 38.06 | 41.65 | 43.68 | |||||
Cash Conversion Cycle (Average Days) | -34.18 | -27.75 | -28.95 | -32.15 | -33.82 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 24.64 | 46.93 | 45.13 | 39.89 | 35.64 | |||||
Total Debt / Total Capital | 19.77 | 31.94 | 31.1 | 28.52 | 26.27 | |||||
LT Debt/Equity | 16.97 | 36.32 | 29.8 | 25.55 | 24.52 | |||||
Long-Term Debt / Total Capital | 13.62 | 24.72 | 20.54 | 18.26 | 18.08 | |||||
Total Liabilities / Total Assets | 41.39 | 47.83 | 47.36 | 48.14 | 46.79 | |||||
EBIT / Interest Expense | -9.67 | -20.79 | -4.31 | 6.32 | 24.8 | |||||
EBITDA / Interest Expense | 3.85 | -12.83 | 1.8 | 11.89 | 31.05 | |||||
(EBITDA - Capex) / Interest Expense | -28.64 | -21.16 | -1.82 | 7.06 | 22.82 | |||||
Total Debt / EBITDA | 18.1 | -4.25 | 20.4 | 3.58 | 1.48 | |||||
Net Debt / EBITDA | -27.98 | 4.18 | -18.94 | -4.99 | -2.57 | |||||
Total Debt / (EBITDA - Capex) | -2.43 | -2.58 | -20.14 | 6.03 | 2.02 | |||||
Net Debt / (EBITDA - Capex) | 3.76 | 2.53 | 18.71 | -8.41 | -3.5 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.75 | 56.04 | 22.79 | 25.82 | 21.99 | |||||
Gross Profit, 1 Yr. Growth % | 5.17 | 24.74 | 45.39 | 57.39 | 33.54 | |||||
EBITDA, 1 Yr. Growth % | -87.51 | -1.25K | -100.65 | 4.02K | 173.82 | |||||
EBITA, 1 Yr. Growth % | -771.85 | 1.06K | -75.06 | -250.73 | 260.57 | |||||
EBIT, 1 Yr. Growth % | 3.82K | 794.12 | -73.72 | -236.25 | 268.54 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 110.52 | -599.96 | -71.6 | -307.28 | 158.41 | |||||
Net Income, 1 Yr. Growth % | 110.31 | -599.93 | -71.59 | -307.23 | 158.43 | |||||
Normalized Net Income, 1 Yr. Growth % | -234.58 | 942.87 | -71.99 | -234.66 | 252.4 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 105.26 | -600 | -72.05 | -293.24 | 168.72 | |||||
Accounts Receivable, 1 Yr. Growth % | 103.54 | 6.33 | 12.21 | 35.54 | 8.18 | |||||
Inventory, 1 Yr. Growth % | 69.49 | 7.74 | 56.56 | 10.42 | 44.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 158.87 | 63.93 | -2.69 | 17.01 | 16.4 | |||||
Total Assets, 1 Yr. Growth % | 26.18 | 44.47 | 1.59 | 19.86 | 10.69 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.12 | 43.24 | 3.76 | 23.95 | 17.12 | |||||
Common Equity, 1 Yr. Growth % | 6.06 | 28.58 | 2.51 | 18.06 | 13.58 | |||||
Cash From Operations, 1 Yr. Growth % | 52.04 | -147.33 | -384.47 | 255.1 | 41.03 | |||||
Capital Expenditures, 1 Yr. Growth % | 275.97 | -43.06 | -36.39 | 20.03 | 59.89 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -585.46 | -69.91 | -321.55 | 231.59 | 4.26 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -532.91 | -80.39 | -396.54 | 207.6 | 3.96 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 32.61 | 36.07 | 38.42 | 24.3 | 23.89 | |||||
Gross Profit, 2 Yr. CAGR % | 50.47 | 16.06 | 34.67 | 51.27 | 44.97 | |||||
EBITDA, 2 Yr. CAGR % | -76.3 | 120.81 | -69.8 | -14.98 | 962.64 | |||||
EBITA, 2 Yr. CAGR % | -50.04 | 615.81 | 82.91 | -39.73 | 133.13 | |||||
EBIT, 2 Yr. CAGR % | -47.62 | 1.52K | 64.73 | -41.11 | 124.08 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -79.81 | 224.43 | 19.17 | -23.27 | 131.44 | |||||
Net Income, 2 Yr. CAGR % | -79.81 | 224.25 | 19.17 | -23.28 | 131.42 | |||||
Normalized Net Income, 2 Yr. CAGR % | -56.53 | 279.72 | 83.93 | -39.48 | 117.84 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -86.44 | 220.36 | 18.21 | -26.51 | 127.88 | |||||
Accounts Receivable, 2 Yr. CAGR % | 120.4 | 38.93 | 9.23 | 23.33 | 21.09 | |||||
Inventory, 2 Yr. CAGR % | 7.96 | 104.53 | 29.88 | 31.48 | 26.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 87.02 | 106 | 26.3 | 6.71 | 16.71 | |||||
Total Assets, 2 Yr. CAGR % | 17.5 | 35.02 | 21.15 | 10.35 | 15.18 | |||||
Tangible Book Value, 2 Yr. CAGR % | 12 | 26.16 | 21.91 | 13.4 | 20.48 | |||||
Common Equity, 2 Yr. CAGR % | 6.27 | 16.78 | 14.81 | 10.01 | 15.8 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.92 | -15.17 | 16.04 | 217.83 | 123.78 | |||||
Capital Expenditures, 2 Yr. CAGR % | 125.33 | 73.74 | -39.82 | -12.62 | 38.54 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 80.5 | 17.41 | 20.99 | 173.09 | 85.93 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 76.74 | -10.59 | 29.93 | 204.07 | 78.82 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 49.74 | 40.37 | 31.49 | 34.09 | 23.52 | |||||
Gross Profit, 3 Yr. CAGR % | 39.49 | 42.6 | 25.11 | 41.85 | 45.11 | |||||
EBITDA, 3 Yr. CAGR % | -52.69 | 29.88 | -66.18 | 116.55 | 25.55 | |||||
EBITA, 3 Yr. CAGR % | -11.72 | 23.94 | 145.75 | 69.53 | 9.41 | |||||
EBIT, 3 Yr. CAGR % | -9.15 | 22.66 | 330.97 | 52.99 | 8.52 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -37.18 | -41.15 | 44.06 | 43.32 | 15.01 | |||||
Net Income, 3 Yr. CAGR % | -37.1 | -41.15 | 44.01 | 43.3 | 15.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | -20.88 | 26.51 | 67.24 | 64.16 | 8.88 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -60.2 | -54.86 | 42.08 | 39.26 | 13.22 | |||||
Accounts Receivable, 3 Yr. CAGR % | 86.68 | 66.38 | 29.38 | 17.38 | 18.06 | |||||
Inventory, 3 Yr. CAGR % | 74.12 | 42.22 | 87.1 | 23.04 | 35.83 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 147.71 | 78.99 | 60.44 | 23.13 | 9.85 | |||||
Total Assets, 3 Yr. CAGR % | 25.82 | 25.88 | 22.8 | 20.72 | 10.46 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3 | 21.57 | 18.2 | 22.59 | 14.63 | |||||
Common Equity, 3 Yr. CAGR % | 34.05 | 13.24 | 11.81 | 15.88 | 11.19 | |||||
Cash From Operations, 3 Yr. CAGR % | 201.18 | -24.12 | 26.98 | 68.47 | 142.42 | |||||
Capital Expenditures, 3 Yr. CAGR % | 147.78 | 59.75 | 24.29 | -24.25 | 6.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 308.84 | -2.56 | 88.58 | 70.17 | 98.11 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 305.93 | -16.76 | 90.21 | 73.95 | 112.62 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 95.2 | 69.01 | 45.33 | 33.7 | 28.4 | |||||
Gross Profit, 5 Yr. CAGR % | 64.19 | 48.2 | 38.27 | 46 | 32.71 | |||||
EBITDA, 5 Yr. CAGR % | -45.26 | 22.68 | -49.52 | 14.12 | 63.81 | |||||
EBITA, 5 Yr. CAGR % | -19.3 | 29.56 | 8.73 | -4.29 | 138.97 | |||||
EBIT, 5 Yr. CAGR % | -16.96 | 29.11 | 8.89 | -5.87 | 229.65 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -12.6 | 16.65 | -18.84 | -34.56 | 74.14 | |||||
Net Income, 5 Yr. CAGR % | -14.85 | 32.38 | -18.78 | -34.56 | 74.1 | |||||
Normalized Net Income, 5 Yr. CAGR % | -24.35 | 29.22 | 11.48 | -3 | 84.8 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -38.24 | -12.27 | -38.48 | -45.14 | 71.64 | |||||
Accounts Receivable, 5 Yr. CAGR % | 43.71 | 49.49 | 47.25 | 47.6 | 26 | |||||
Inventory, 5 Yr. CAGR % | 126.3 | 99.34 | 82.77 | 37.82 | 59.99 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 98.95 | 113.76 | 89.2 | 45.54 | 41.26 | |||||
Total Assets, 5 Yr. CAGR % | 31.18 | 36 | 23.93 | 19.42 | 19.7 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.24 | 16.13 | 10.19 | 18.24 | 19.11 | |||||
Common Equity, 5 Yr. CAGR % | 40.78 | 37.43 | 25.99 | 11.94 | 13.39 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.18 | 15.9 | 105.66 | 34.58 | 59.28 | |||||
Capital Expenditures, 5 Yr. CAGR % | 99.39 | 91.18 | 50.69 | 25.49 | 29.8 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 20.28 | 148.31 | 72.22 | 88.08 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 9.61 | 154.29 | 72.97 | 86.07 |
- Stock Market
- Equities
- 3690 Stock
- Financials Meituan
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















